Raffles Medical Group Valuation

RAFLFDelisted Stock  USD 0.74  0.00  0.00%   
Raffles Medical is overvalued. Raffles Medical Group holds a recent Real Value of $0.68 per share. The prevailing price of the company is $0.74. Our model determines the value of Raffles Medical Group from analyzing the company fundamentals such as Return On Equity of 0.11, shares outstanding of 1.85 B, and Operating Margin of 0.19 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
0.74
Please note that Raffles Medical's price fluctuation is very steady at this time. Calculation of the real value of Raffles Medical Group is based on 3 months time horizon. Increasing Raffles Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Raffles pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Raffles Medical Group. Since Raffles Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Raffles Pink Sheet. However, Raffles Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.74 Real  0.68 Hype  0.74 Naive  0.74
The real value of Raffles Pink Sheet, also known as its intrinsic value, is the underlying worth of Raffles Medical Group Company, which is reflected in its stock price. It is based on Raffles Medical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Raffles Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
0.68
Real Value
0.81
Upside
Estimating the potential upside or downside of Raffles Medical Group helps investors to forecast how Raffles pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Raffles Medical more accurately as focusing exclusively on Raffles Medical's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.750.750.75
Details
Hype
Prediction
LowEstimatedHigh
0.740.740.74
Details
Naive
Forecast
LowNext ValueHigh
0.740.740.74
Details

Raffles Medical Total Value Analysis

Raffles Medical Group is at this time expected to have takeover price of 1.82 B with market capitalization of 1.92 B, debt of 77.91 M, and cash on hands of 289.07 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Raffles Medical fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
1.82 B
1.92 B
77.91 M
289.07 M

Raffles Medical Investor Information

About 55.0% of the company outstanding shares are owned by corporate insiders. The book value of Raffles Medical was at this time reported as 0.51. The company last dividend was issued on the 9th of May 2022. Raffles Medical Group had 3:1 split on the 9th of May 2016. Raffles Medical Group is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.

Raffles Medical Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Raffles Medical has an asset utilization ratio of 46.84 percent. This implies that the Company is making $0.47 for each dollar of assets. An increasing asset utilization means that Raffles Medical Group is more efficient with each dollar of assets it utilizes for everyday operations.

Raffles Medical Ownership Allocation

Raffles Medical owns a total of 1.85 Billion outstanding shares. Raffles Medical has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.

Raffles Medical Profitability Analysis

The company reported the revenue of 723.79 M. Net Income was 84.17 M with profit before overhead, payroll, taxes, and interest of 193.55 M.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Raffles Medical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Raffles Medical and how it compares across the competition.

About Raffles Medical Valuation

The pink sheet valuation mechanism determines Raffles Medical's current worth on a weekly basis. Our valuation model uses a comparative analysis of Raffles Medical. We calculate exposure to Raffles Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Raffles Medical's related companies.
Raffles Medical Group Ltd provides integrated private healthcare services primarily in Singapore, Greater China, Vietnam, Cambodia, and Japan. Raffles Medical Group Ltd operates as a subsidiary of Raffles Medical Holdings Pte. Raffles Medical operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange. It employs 2700 people.

8 Steps to conduct Raffles Medical's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Raffles Medical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Raffles Medical's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Raffles Medical's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Raffles Medical's revenue streams: Identify Raffles Medical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Raffles Medical's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Raffles Medical's growth potential: Evaluate Raffles Medical's management, business model, and growth potential.
  • Determine Raffles Medical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Raffles Medical's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Raffles Medical Growth Indicators

Investing in growth stocks can be very risky. If the company such as Raffles Medical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding1.9 B
Quarterly Earnings Growth Y O Y0.512
Forward Price Earnings22.7273
Retained Earnings484 M
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Consideration for investing in Raffles Pink Sheet

If you are still planning to invest in Raffles Medical Group check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Raffles Medical's history and understand the potential risks before investing.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Money Managers
Screen money managers from public funds and ETFs managed around the world
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets